S&P 500   3,971.46 (+0.88%)
DOW   32,207.44 (+0.55%)
QQQ   311.06 (+1.61%)
AAPL   159.68 (+1.17%)
MSFT   279.03 (+2.48%)
META   205.26 (+2.73%)
GOOGL   105.51 (+2.07%)
AMZN   99.59 (+0.90%)
TSLA   193.08 (+1.01%)
NVDA   272.35 (+2.90%)
NIO   9.29 (+2.20%)
BABA   86.05 (+2.87%)
AMD   101.19 (+3.70%)
T   18.49 (+0.54%)
F   11.56 (+0.70%)
MU   61.17 (+5.16%)
CGC   1.91 (+1.33%)
GE   91.42 (+2.04%)
DIS   96.27 (+1.44%)
AMC   4.45 (+2.53%)
PFE   40.34 (+0.82%)
PYPL   72.99 (-1.82%)
NFLX   317.99 (+8.20%)
S&P 500   3,971.46 (+0.88%)
DOW   32,207.44 (+0.55%)
QQQ   311.06 (+1.61%)
AAPL   159.68 (+1.17%)
MSFT   279.03 (+2.48%)
META   205.26 (+2.73%)
GOOGL   105.51 (+2.07%)
AMZN   99.59 (+0.90%)
TSLA   193.08 (+1.01%)
NVDA   272.35 (+2.90%)
NIO   9.29 (+2.20%)
BABA   86.05 (+2.87%)
AMD   101.19 (+3.70%)
T   18.49 (+0.54%)
F   11.56 (+0.70%)
MU   61.17 (+5.16%)
CGC   1.91 (+1.33%)
GE   91.42 (+2.04%)
DIS   96.27 (+1.44%)
AMC   4.45 (+2.53%)
PFE   40.34 (+0.82%)
PYPL   72.99 (-1.82%)
NFLX   317.99 (+8.20%)
S&P 500   3,971.46 (+0.88%)
DOW   32,207.44 (+0.55%)
QQQ   311.06 (+1.61%)
AAPL   159.68 (+1.17%)
MSFT   279.03 (+2.48%)
META   205.26 (+2.73%)
GOOGL   105.51 (+2.07%)
AMZN   99.59 (+0.90%)
TSLA   193.08 (+1.01%)
NVDA   272.35 (+2.90%)
NIO   9.29 (+2.20%)
BABA   86.05 (+2.87%)
AMD   101.19 (+3.70%)
T   18.49 (+0.54%)
F   11.56 (+0.70%)
MU   61.17 (+5.16%)
CGC   1.91 (+1.33%)
GE   91.42 (+2.04%)
DIS   96.27 (+1.44%)
AMC   4.45 (+2.53%)
PFE   40.34 (+0.82%)
PYPL   72.99 (-1.82%)
NFLX   317.99 (+8.20%)
S&P 500   3,971.46 (+0.88%)
DOW   32,207.44 (+0.55%)
QQQ   311.06 (+1.61%)
AAPL   159.68 (+1.17%)
MSFT   279.03 (+2.48%)
META   205.26 (+2.73%)
GOOGL   105.51 (+2.07%)
AMZN   99.59 (+0.90%)
TSLA   193.08 (+1.01%)
NVDA   272.35 (+2.90%)
NIO   9.29 (+2.20%)
BABA   86.05 (+2.87%)
AMD   101.19 (+3.70%)
T   18.49 (+0.54%)
F   11.56 (+0.70%)
MU   61.17 (+5.16%)
CGC   1.91 (+1.33%)
GE   91.42 (+2.04%)
DIS   96.27 (+1.44%)
AMC   4.45 (+2.53%)
PFE   40.34 (+0.82%)
PYPL   72.99 (-1.82%)
NFLX   317.99 (+8.20%)
NASDAQ:EYPT

EyePoint Pharmaceuticals - EYPT Stock Reddit Activity & Social Media Sentiment

$2.33
-0.06 (-2.51%)
(As of 03/23/2023 01:27 PM ET)
Add
Compare
Today's Range
$2.29
▼
$2.49
50-Day Range
$2.35
▼
$5.04
52-Week Range
$2.19
▼
$13.18
Volume
127,359 shs
Average Volume
286,477 shs
Market Capitalization
$79.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.00

Reddit Posts Over Time

View Trending Reddit Stocks

Media Mentions Over Time



View Trending Media Stocks

MarketBeat New Follows Over Time

View Trending Stocks on MarketBeat

MarketBeat Searches Over Time



Recieve EYPT News and Ratings via Email

Sign-up to receive the latest news and ratings for EyePoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

EYPT Social Media Mentions

Recent EYPT Stock Reddit Threads

January 13th, 2023  1:02 PM  |  facelesspair |  pennystocks
FINALLY!!

I was weary about using some of the advice on this page but finally said fuck it and bought some stock on some suggestions I saw. Went easy and bought $300 worth of $EYPT at $3.73. THANK YOU. Found my new page to look at

January 12th, 2023  11:54 AM  |  StockyJ122 |  RobinHoodPennyStocks
$EYPT +25% today

Told you about it yesterday --

January 11th, 2023  11:07 AM  |  StockyJ122 |  RobinHoodPennyStocks
EYPT -- $52 price target by Guggenheim

“EYPT is using a completely different paradigm (long-lasting TKI erodible insert to keep dry eyes dry) to extend dosing and reduce the treatment burden in patients with wet AMD. This is a pivotal year for the company as data from the randomized DAVIO2 study in wet AMD are expected …

This page (NASDAQ:EYPT) was last updated on 3/23/2023 by MarketBeat.com Staff